AI assistant
INTEL CORP — Director's Dealing 2006
Jul 25, 2006
29808_dirs_2006-07-25_430c522f-d807-493c-9d3a-444ecadf1fde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTEL CORP (INTC)
CIK: 0000050863
Period of Report: 2006-07-21
Reporting Person: SHAW JANE E (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-07-21 | Restricted Stock Units | $0 | A | 2823 | Acquired | 2007-07-21 | CMN STK (2823) | Direct |
| 2006-07-21 | Restricted Stock Units | $0 | A | 2823 | Acquired | 2008-07-21 | CMN STK (2823) | Direct |
| 2006-07-21 | Restricted Stock Units | $0 | A | 2824 | Acquired | 2009-07-21 | CMN STK (2824) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| COMMON | 194237 | Indirect |
Footnotes
F1: Includes 1,189 shares acquired under the Intel Corporation Dividend Reinvestment Plan during March 2006.
F2: Dr. Shaw owns directly 16,446 phantom share units acquired under the Deferral Plan for Outside Directors.
F3: Each restricted stock unit represents the right to receive, following vesting, one share of Intel Corporation common stock.
F4: Unless earlier forfeited under the terms of the RSU, 25% of the award vests and converts into the right to receive common stock on each anniversary of the grant date.
F5: Dr. Shaw holds 149,000 options with the right to buy Intel Corporation common stock.